Methylcellulose

Summary

Methylcellulose (CHEMBL2109198) is an approved unknown (ATC A06AC06); indicated across 3 conditions including constipation disorder and chronic kidney disease.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Unknown
• ATC class: A06AC06
• Indications: 3 conditions
• Clinical trials: 13

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2109198
Name	Methylcellulose
Type	Unknown
Max phase	4
ATC	A06AC06

Also known as: Benecel mc a15c, Celevac, Cellucon, Cellulose methyl ether, Citrucel, Cologel, E-461, FEMA NO. 2696, INS NO.461, INS-461, Methycellulose, Methyl ether of cellulose

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

3 indications (1 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
constipation disorder	4	MONDO:0002203	HP:0002019
chronic kidney disease	2	MONDO:0005300	EFO:0003884
cataract	1	MONDO:0005129	MONDO:0005129

Clinical trials

Total trials: 13.

Phase distribution

Phase	Trials
PHASE4	4
Not specified	4
PHASE2	3
PHASE3	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00865540	PHASE4	UNKNOWN	Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies
NCT00934973	PHASE4	COMPLETED	Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)
NCT03452891	PHASE4	COMPLETED	Effect of Locally-Applied Simvastatin on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance Patients
NCT04668859	PHASE4	TERMINATED	Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome
NCT06514586	PHASE3	NOT_YET_RECRUITING	The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy
NCT01497951	PHASE3	COMPLETED	Photodynamic Therapy for Oral Precursor Lesions
NCT01528800	PHASE2	COMPLETED	Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
NCT01532401	PHASE2	COMPLETED	Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers
NCT03484507	PHASE2	COMPLETED	Parasitic Ulcer Treatment Trial Pilot
NCT06551961	Not specified	RECRUITING	Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation
NCT05911347	Not specified	COMPLETED	Effect of Modified Cellulose on Colonic Fermentation of Inulin
NCT06291272	Not specified	COMPLETED	Effect of Methylcellulose or Psyllium on Fermentation of inUlin Assessed USing MRI
NCT06551948	Not specified	COMPLETED	Effect of MethylceIlulose or Psyllium on Fermentation of Inulin Assessed Using a Gas Sensing Capsule

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).